MDM2

MDM2 inhibitors disrupt the binding of mouse double minute 2 homolog (MDM2) to the tumor suppressor p53. In 1992 the MDM2 protein was shown to form a complex with p53 and inhibit p53-mediated transactivation. MDM2 is also an E3 ubiquitin ligase that promotes the rapid degradation of p53, as reported in 1997. Nutlins, reported in 2004, occupy the p53-binding pocket of MDM2 and activate the p53 pathway in cells and in vivo. Nutlin 3a is the active enantiomer of nutlin-3, and Nutlin 3b is a much weaker enantiomer used as a control. RG7112 and APG-115 are further MDM2 inhibitors, while MD-224 is a degrader that removes MDM2 protein. SJ 172550 targets the MDM2 relative MDM4 (also called MDMX).

Items 101-112 of 112

  • (R)-NVP-CGM097
    Cat. No.
    A53906

    (R)-NVP-CGM097

    Synonyms: (R)-CGM097

    (R)-NVP-CGM097 is the R-enantiomer of NVP-CGM097, a highly selective inhibitor of the MDM2 protein with an IC50 of 1.7 nM for human MDM2. This compound interrupts the interaction between MDM2 and p53, leading to the reactivation of p53-dependent pathways. (R)-NVP-CGM097 is essential for research applications involving cancer biology, specifically in studies focused on tumor suppression and the regulation of the cell cycle.

    2 mg
    $210.00
    5 mg
    $365.00
    All 2 sizes
  • p53-MDM2-IN-3
    Cat. No.
    A53908

    p53-MDM2-IN-3

    p53-MDM2-IN-3 is a potent p53-MDM2 inhibitor with a Ki value of 0.25 μM, demonstrating oral bioavailability. This compound exhibits significant antitumor activity through its inhibition of the NF-κB signaling pathway. It serves as a valuable tool for cancer research, particularly in studies focused on targeting the p53-MDM2 interaction and the subsequent effects on tumor proliferation and survival.

    1 mg
    $205.00
    5 mg
    $940.00
    All 3 sizes
  • MDM2-p53-IN-18
    Cat. No.
    A53912

    MDM2-p53-IN-18

    MDM2-p53-IN-18 is a potent inhibitor of the MDM2-p53 protein-protein interaction. This compound effectively disrupts the binding of MDM2 to the tumor suppressor p53, leading to the stabilization and activation of p53. It demonstrates significant biological activity in promoting apoptosis and cell cycle arrest in cancer cells, making it valuable for research applications in oncology and drug discovery targeting p53-related pathways.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Nutlin-2
    Cat. No.
    A53913

    Nutlin-2

    Nutlin-2 is a selective inhibitor of the interaction between MDM2 and p53, exhibiting an IC50 of 0.14 μM. By occupying the hydrophobic pocket of MDM2, Nutlin-2 effectively disrupts the protein-protein interaction crucial for the regulation of p53, allowing for the stabilization and activation of this tumor suppressor. This compound is primarily utilized in cancer research to study p53-mediated pathways and to explore therapeutic avenues in tumors with MDM2 overexpression.

    25 mg
    $1,275.00
    50 mg
    $1,625.00
    All 3 sizes
  • Caylin-2
    Cat. No.
    A53914

    Caylin-2

    Caylin-2 is a Nutlin-3 analog that functions as an inhibitor of the MDM2 protein. This compound demonstrates the ability to bind to Bcl-XL, which may influence apoptotic pathways. Caylin-2 is utilized in research focused on cancer biology, particularly in studies assessing MDM2's role in tumor suppression and cell survival mechanisms.

    1 mg
    $185.00
    5 mg
    $810.00
    All 3 sizes
  • RO5353
    Cat. No.
    A53915

    RO5353

    RO5353 is an orally active MDM2 inhibitor that effectively disrupts the p53-MDM2 interaction, with an IC50 of 7 nM for MDM2. It demonstrates potent inhibitory effects on the proliferation of wild-type p53 cancer cells, achieving an average IC50 of 7 nM. In vivo studies reveal that RO5353 possesses significant antitumor efficacy and favorable pharmacokinetic properties in murine models, making it a valuable tool for cancer research focused on p53 pathway modulation.

    25 mg
    $2,535.00
    50 mg
    $3,265.00
    All 3 sizes
  • MEL24
    Cat. No.
    A80500

    MEL24

    MEL24 is an inhibitor of the Mdm2 E3 ligase, which plays a critical role in regulating p53 protein levels. This compound significantly reduces cell survival and enhances sensitivity to DNA-damaging agents in a p53-dependent manner. MEL24 is primarily utilized in antitumor research, contributing to studies aimed at understanding and overcoming resistance in cancer therapies.

    5 mg
    $125.00
    10 mg
    $210.00
    All 5 sizes
  • (rel)-Nutlin carboxylic acid
    Cat. No.
    A80605

    (rel)-Nutlin carboxylic acid

    (rel)-Nutlin carboxylic acid is an MDM2 ligand derived from Nutlin 3, targeting the MDM2 protein to inhibit its interaction with p53. This compound plays a crucial role in cancer research, particularly in the study of p53 pathway modulation and potential therapeutic interventions. It can also be utilized in the development of PROTACs when linked to other proteins, facilitating targeted protein degradation.

    Out of stock

    All 3 sizes
  • MEL23
    Cat. No.
    A80647

    MEL23

    MEL23 is an MDM2 E3 ligase inhibitor that specifically targets the E3 ligase activity of the MDM2-MDMX complex. This compound effectively inhibits the ubiquitination of MDM2 and p53, leading to decreased viability in cells expressing wild-type p53. Additionally, MEL23 stabilizes MDM2 through a mechanism that does not involve p53 transcription, making it a valuable tool for research into cancer biology and therapeutic strategies targeting the p53 pathway.

    Out of stock

    All 3 sizes
  • NVP-CGM097 (stereoisomer)
    Cat. No.
    B10893

    NVP-CGM097 (stereoisomer)

    Synonyms: CGM097 stereoisomer

    NVP-CGM097 (stereoisomer) is a stereoisomer of NVP-CGM097, a potent and selective inhibitor of the MDM2 protein. By targeting the MDM2 oncogene, which regulates p53 tumor suppressor pathways, this compound is essential for research applications focused on cancer biology and the modulation of apoptosis. Its use may provide insights into therapeutic strategies for tumors with MDM2 overexpression.

    2 mg
    $245.00
    5 mg
    $445.00
    All 5 sizes
  • (4R,5S)-YX-02-030
    Cat. No.
    B10899

    (4R,5S)-YX-02-030

    (4R,5S)-YX-02-030 is a stereoisomer of YX-02-030, functioning as a PROTAC (Proteolysis Targeting Chimera) designed to promote the degradation of MDM2. This compound exhibits potent biological activity in disrupting MDM2-mediated degradation of p53, thereby enhancing p53 activity and providing insights into cancer therapy. Its application is particularly relevant in studies of tumor suppression and cellular signaling pathways involving MDM2 and p53 interactions.

    1 mg
    $455.00
    5 mg
    $1,080.00
    All 3 sizes
  • Brigimadlin enantiomer
    Cat. No.
    B10928

    Brigimadlin enantiomer

    Synonyms: BI 907828 enantiomer

    Brigimadlin enantiomer is a selective inhibitor of the MDM2 protein, which plays a critical role in regulating the p53 tumor suppressor pathway. This compound exhibits potent anti-cancer activity by promoting p53-mediated apoptosis in tumor cells. It is widely utilized in cancer research for investigating therapeutic strategies targeting MDM2-p53 interactions.

    1 mg
    $160.00
    5 mg
    $285.00
    All 6 sizes

Items 101-112 of 112

Added to your cart

View Cart Checkout

    Loading...